Chiara Moretti

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri et al. · Cardiovascular Diabetology · 2020 · 114 citations · Full text

Medicine, Internal Medicine, Critical Care Cardiology +11

Conversion of octanoic acid into long-chain saturated fatty acids in premature infants fed a formula containing medium-chain triglycerides

Virgilio Carnielli, Esther Sulkers, Chiara Moretti et al. · Metabolism · 1994 · 86 citations

Life Sciences, Nutritional Sciences, Pediatrics +16

Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults

Nicola Napoli, Rocky Strollo, Giuseppe Defeudis et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 53 citations · Full text

Medicine, Endocrinology, Immunology +16

Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy

Gaetano Leto, Luca D’Onofrio, Federica Lucantoni et al. · Diabetes/Metabolism Research and Reviews · 2018 · 37 citations

Medicine, Cardiology, Pathology +16